CLINICAL_TRIALS
trial_result
· 2021-09-27
Clinical Trial Update: MDX-010 in Treating Patients With Stage IV Pancreatic Cancer That Cannot Be Removed By Surgery [Phase 2]
Summary
Phase 2 trial update for MDX-010 in stage IV pancreatic cancer unsuitable for surgery; results posted after completion.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bristol-Myers Squibb | Conditions: Pancreatic Cancer | Phase 2 | Status: COMPLETED | Results posted: 2021-09-27